Site-specific antitumour effects of 2 pyrimidinone compounds in rats.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007369:Interferon Inducers / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D051379:Mice; D010587:Phagocytosis / Q000187:drug effects
D000970:Antineoplastic Agents; D007369:Interferon Inducers; C033561:2-amino-5-iodo-6-phenyl-4-pyrimidinone; D003596:Cytosine; C033560:bropirimine